Tag | Content |
---|---|
UniProt Accession | TRXR1_HUMAN; Q16881; |
Entrez ID | 7296 |
GenBank Protein ID | NM_001093771.2; NM_001261445.1; NM_001261446.1; NM_003330.3; NM_182729.2; NM_182742.2; NM_182743.2; |
GenBank Nucleotide ID | NP_001087240.1; NP_001248374.1; NP_001248375.1; NP_003321.3; NP_877393.1; NP_877419.1; NP_877420.1; |
Protein Name | Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thior |
Gene Name | TXNRD1; GRIM12; KDRF |
Organism | Homo sapiens |
NCBI Taxa ID | 9606 |
Functional Description | Isoform 1 may possess glutaredoxin activity as well as thioredoxin reductase activity and induces actin and tubulin polymerization, leading to formation of cell membrane protrusions. Isoform 4 enhances the transcriptional activity of estrogen receptors alpha and beta while isoform 5 enhances the transcriptional activity of the beta receptor only. Isoform 5 also mediates cell death induced by a combination of interferon-beta and retinoic acid. |
Sequence (Fasta) | MGCAEGKAVA AAAPTELQTK GKNGDGRRRS AKDHHPGKTL PENPAGFTST ATADSRALLQ 60 AYIDGHSVVI FSRSTCTRCT EVKKLFKSLC VPYFVLELDQ TEDGRALEGT LSELAAETDL 120 PVVFVKQRKI GGHGPTLKAY QEGRLQKLLK MNGPEDLPKS YDYDLIIIGG GSGGLAAAKE 180 AAQYGKKVMV LDFVTPTPLG TRWGLGGTCV NVGCIPKKLM HQAALLGQAL QDSRNYGWKV 240 EETVKHDWDR MIEAVQNHIG SLNWGYRVAL REKKVVYENA YGQFIGPHRI KATNNKGKEK 300 IYSAERFLIA TGERPRYLGI PGDKEYCISS DDLFSLPYCP GKTLVVGASY VALECAGFLA 360 GIGLDVTVMV RSILLRGFDQ DMANKIGEHM EEHGIKFIRQ FVPIKVEQIE AGTPGRLRVV 420 AQSTNSEEII EGEYNTVMLA IGRDACTRKI GLETVGVKIN EKTGKIPVTD EEQTNVPYIY 480 AIGDILEDKV ELTPVAIQAG RLLAQRLYAG STVKCDYENV PTTVFTPLEY GACGLSEEKA 540 VEKFGEENIE VYHSYFWPLE WTIPSRDNNK CYAKIICNTK DNERVVGFHV LGPNAGEVTQ 600 GFAAALKCGL TKKQLDSTIG IHPVCAEVFT TLSVTKRSGA SILQAGCUG |
|
Database | Annotation |
---|---|
CTD (Curated) (count: 8) (view all) | MESH:D000236
; Adenoma MESH:D018827 ; Carcinoma, Lewis Lung MESH:D015179 ; Colorectal Neoplasms MESH:D003877 ; Dermatitis, Contact MESH:D004827 ; Epilepsy MESH:D008654 ; Mesothelioma |
GWASdb (count: 5) | rs4545635; Alzheimer's disease; Alzheimer's disease
rs4964735; Type 2 diabetes; type 2 diabetes mellitus rs10861184; Alcohol dependence; alcohol dependence rs10735392; Urinary metabolites; kidney disease rs10861197; Glucose levels; type 2 diabetes mellitus |
PTM | Modification Sites |
---|---|
Phosphorylation (count: 13) (view all) | 160 GPEDLPKSYDYDLII dbPAF
161 PEDLPKSYDYDLIII dbPAF 163 DLPKSYDYDLIIIGG dbPAF 184 AAKEAAQYGKKVMVL dbPAF 201 VTPTPLGTRWGLGGT dbPAF 277 LREKKVVYENAYGQF dbPAF |
Acetylation (count: 13) (view all) | 179 SGGLAAAKEAAQYGK PLMD
217 VNVGCIPKKLMHQAA PLMD 239 DSRNYGWKVEETVKH PLMD 245 WKVEETVKHDWDRMI PLMD 274 RVALREKKVVYENAY PLMD 300 TNNKGKEKIYSAERF PLMD |
Ubiquitination (count: 25) (view all) | 126 DLPVVFVKQRKIGGH PLMD
179 SGGLAAAKEAAQYGK PLMD 187 EAAQYGKKVMVLDFV PLMD 217 VNVGCIPKKLMHQAA PLMD 218 NVGCIPKKLMHQAAL PLMD 239 DSRNYGWKVEETVKH PLMD |
Sumoylation (count: 1) | 405 IRQFVPIKVEQIEAG PLMD |
Malonylation (count: 3) | 274 RVALREKKVVYENAY PLMD
300 TNNKGKEKIYSAERF PLMD 449 GRDACTRKIGLETVG PLMD |
Succinylation (count: 2) | 245 WKVEETVKHDWDRMI PLMD
405 IRQFVPIKVEQIEAG PLMD |
Network | Interaction | ||
---|---|---|---|
A | B | Source | |